AI and Value-Based Care: Machine Learning’s Potential in Reducing Healthcare Waste

By Michael Awood

October 8, 2023

According to a new study, the United States wastes $1 trillion a year on healthcare. The staggering cost of inefficiency is higher than the world’s 17th-biggest country’s GDP. Waste in healthcare affects patient care, the speed of organisations, and the cost of materials. Mistakes and wasteful spending are more likely in the healthcare system due to its complexity. This severely reduces the effectiveness of treatment.

Value-based care methods were created to deal with this issue. They promote cost-effective clinical results that lead to high-quality care at a fair price. In a data-rich environment, making decisions can become too complicated. These things cause mistakes, which make it harder to get high-value care, which wastes more time and money.

Putting this in perspective, about 80,000 people die every year in the US because of inaccurate outcomes. Even with the most up-to-date training and tools, healthcare still has problems. Maintaining awareness of the growing amount of medical info requires a lot of mental effort.

With the help of Machine Learning, both the number of mistakes and the amount of resources used could go down. Algorithms can now be used to make diagnoses instead of the human equivalent, i.e: radiologists, pathologists, and doctors. By using automations such as event reporting, you can keep patients safe. Putting together local, real-time data from institutions and social media could help with public health management and change how we predict future epidemics.

ML might be able to make personalised treatment plans for each patient based on genetic information, clinical presentation factors, and information about the patient’s past. This means that patients get more personalised care, go through fewer therapies that are unsuccessful, and have better overall outcomes.

But these changes also bring about new problems. Problems exist with both the quality of the data and our ability to understand the data that machines create. Accountability for mistakes and bad outcomes, as well as protecting patients’ privacy, are challenging.

Rising healthcare costs not only hurt countries in significant amounts, but they also threaten the foundations of value-based medicine. When it comes to keeping our healthcare system safe, ML shows itself to be a strong tool with immense potential. While there isn’t a guaranteed way to make healthcare better without also making it more efficient, ML shows promise in this area.

Reference url

Recent Posts

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.